A Novel Pathogenic Variant in the MN1 Gene in a Patient Presenting with Rhombencephalosynapsis and Craniofacial Anomalies, Expanding MN1 C-terminal Truncation Syndrome

Abstract

Meningioma-1 is a transcription activator that regulates mammalian palate development and is required for appropriate osteoblast proliferation, motility, differentiation, and function. Microdeletions involving the MN1 gene have been linked to syndromes including craniofacial anomalies, such as Toriello–Carey syndrome. Recently, truncating variants in the C-terminal portion of the MN1 transcriptional factor have been linked to a characteristic and distinct phenotype presenting with craniofacial anomalies and partial rhombencephalosynapsis, a rare brain malformation characterized by midline fusion of the cerebellar hemispheres with partial or complete loss of the cerebellar vermis. It has been called MN1 C-terminal truncation (MCTT) syndrome or CEBALID (Craniofacial defects, dysmorphic Ears, Brain Abnormalities, Language delay, and Intellectual Disability) and suggested to be caused by dominantly acting truncated protein MN1 instead of haploinsufficiency. As a proto-oncogene, MN1 is also involved in familial meningioma. In this study, we present a novel case of MCTT syndrome in a female patient presenting with craniofacial anomalies and rhombencephalosynapsis, harboring a de novo pathogenic variant in the MN1 gene: c.3686_3698del, p.(Met1229Argfs*87).

Keywords

rhombencephalosynapsis - MN1 - MN1 C-terminal truncation (MCTT) syndrome and craniofacial anomalies

Publication History

Received: 24 September 2020

Accepted: 26 February 2021

Article published online:
14 April 2021

• References

• 1 Zhang X, Dowd DR, Moore MC. et al. Meningioma 1 is required for appropriate osteoblast proliferation, motility, differentiation, and function. J Biol Chem 2009; 284 (27) 18174-18183
• 2 Liu W, Lan Y, Pauws E. et al. The Mn1 transcription factor acts upstream of Tbx22 and preferentially regulates posterior palate growth in mice. Development 2008; 135 (23) 3959-3968
• 3 Lekanne Deprez RH, Groen NA, van Biezen NA. et al. A t(4;22) in a meningioma points to the localization of a putative tumor-suppressor gene. Am J Hum Genet 1991; 48 (04) 783-790
• 4 Lekanne Deprez RH, Riegman PHJ, Groen NA. et al. Cloning and characterization of MN1, a gene from chromosome 22q11, which is disrupted by a balanced translocation in a meningioma. Oncogene 1995; 10 (08) 1521-1528
• 5 Toriello HV, Carey JC. Corpus callosum agenesis, facial anomalies, Robin sequence, and other anomalies: a new autosomal recessive syndrome?. Am J Med Genet 1988; 31 (01) 17-23
• 6 Lacombe D, Creusot G, Battin J. New case of Toriello-Carey syndrome. Am J Med Genet 1992; 42 (03) 374-376
• 7 Toriello HV, Colley C, Bamshad M. Update on the Toriello-Carey syndrome. Am J Med Genet A 2016; 170 (10) 2551-2558
• 8 Beck M, Peterson JF, McConnell J. et al. Craniofacial abnormalities and developmental delay in two families with overlapping 22q12.1 microdeletions involving the MN1 gene. Am J Med Genet A 2015; 167A [phone]
• 9 Davidson TB, Sanchez-Lara PA, Randolph LM. et al. Microdeletion del(22)(q12.2) encompassing the facial development-associated gene, MN1 (meningioma 1) in a child with Pierre-Robin sequence (including cleft palate) and neurofibromatosis 2 (NF2): a case report and review of the literature. BMC Med Genet 2012; 13 (01) 19
• 10 Mak CCY, Doherty D, Lin AE. et al; University of Washington Center for Mendelian Genomics. MN1 C-terminal truncation syndrome is a novel neurodevelopmental and craniofacial disorder with partial rhombencephalosynapsis. Brain 2020; 143 (01) 55-68
• 11 Miyake N, Takahashi H, Nakamura K. et al. Gain-of-function MN1 truncation variants cause a recognizable syndrome with craniofacial and brain abnormalities. Am J Hum Genet 2020; 106 (01) 13-25
• 12 Li H. Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM. March 2013. Accessed May 5, 2020 http://arxiv.org/abs/1303.3997
• 13 McKenna A, Hanna M, Banks E. et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res 2010; 20 (09) 1297-1303
• 14 Richards S, Aziz N, Bale S. et al; ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015; 17 (05) 405-424
• 15 Pallares LF, Carbonetto P, Gopalakrishnan S. et al. Mapping of craniofacial traits in outbred mice identifies major developmental genes involved in shape determination. PLoS Genet 2015; 11 (11) e1005607
• 16 Reiter R, Brosch S, Lüdeke M. et al. Genetic and environmental risk factors for submucous cleft palate. Eur J Oral Sci 2012; 120 (02) 97-103
• 17 Riedel SS, Haladyna JN, Bezzant M. et al. MLL1 and DOT1L cooperate with meningioma-1 to induce acute myeloid leukemia. J Clin Invest 2016; 126 (04) 1438-1450